Skip to main content
FinSpry Logo
FinSpry
RGEN logo
RGEN
(NASDAQ)
Repligen Corporation
$108.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Repligen (RGEN) Stock Price & Financial Analysis

Repligen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$103.63 - $111.88
52-Week High$175.77
52-Week Low$109.50
Open$109.00
Volume1.17M
Average Volume (3M)1.26M
Market Cap6.14B
Shares Outstanding56.56M
P/E Ratio (TTM)119.00
Price to Sales (P/S)7.88
Price to Book (P/B)2.76
EV/EBITDA33.64
Revenue (TTM)738.26M
Net Income (TTM)48.89M
Free Cash Flow (TTM)92.21M
EPS (TTM)$0.86
Profit Margin6.62%
Operating Margin7.00%
Return on Equity (ROE)2.32%
Debt to Equity0.33
50-Day MA$120.02
200-Day MA$138.14
52-Week Change-13.32%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Repligen

What is the current stock price for RGEN?

As of the latest trading session, RGEN stock trades at $111.74. The 52-week range is $109.50–$175.77, with a day range of $103.63–$111.88.

What is the P/E ratio for RGEN?

Repligen's trailing P/E ratio is 119.0, meaning investors pay $119.0 for every $1 of annual earnings. Repligen operates in the Healthcare sector.

Does RGEN pay dividends?

Repligen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGEN?

Based on 7 analysts, the consensus for RGEN is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RGEN?

Repligen's market capitalization is $6.32B, classifying it as a mid-cap company. Repligen operates in the Healthcare sector within the Medical Instruments & Supplies industry.